What question did this study set out to answer?

The aim is to develop and evaluate AI-driven algorithms for early detection of Alzheimer's disease using home-collectible biomarkers.

March 30, 2026Open Access

Screening for Alzheimer’s disease in the community using an AI-driven screening platform: design of the PREDICTOM study

Key Points

The aim is to develop and evaluate AI-driven algorithms for early detection of Alzheimer's disease using home-collectible biomarkers.
Design and implementation of an AI-driven screening platform.
Collection of biomarkers in community care settings.
Integration of algorithms into a comprehensive clinical pathway.
Enhancement of early detection capabilities for Alzheimer's disease.
Potential for improved accessibility to screening in community settings.

Abstract

PREDICTOM will develop AI-driven algorithms for the early detection of AD using biomarkers that can be collected at home or in the community care setting, and evaluate their integration into a well-defined and comprehensive clinical pathway.

Read Full Paperexternally

AI에게 질문

Bookmark

View Full Paper